FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to field of pharmaceutics and represents pharmaceutical depot, made for introduction by intra-articular injection into joint of subject, suffering from osteoarthritis, which contains microparticles or nanoparticles, composed of N-{5-[(cyclopropylamino)carbonyl]-2-methylphenyl}-3-fluoro-4-[pyridin-2-ylmethoxy)benzamide or its pharmaceutically acceptable salt and biodegradable copolymer lactic acid-glycolic acid.
EFFECT: invention provides controlled release of active agent and long action without toxic side effects.
13 cl, 5 ex, 3 tbl, 9 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| AMIDE DERIVATIVES CARRYING CYCLOPROPYLAMINOCARBONYL SUBSTITUTE, SUITABLE AS CYTOKINE INHIBITORS | 2004 |
|
RU2382028C2 |
| PREPARATIONS WITH PROLONGED RELEASE FOR INTRA-ARTICULAR ADMINISTRATION | 2018 |
|
RU2786830C2 |
| 2-PHENYLAMINOPYRIMIDINE DERIVATIVES AS LEUCINE-RICH REPEAT KINASE 2 (LRRK2) MODULATORS FOR TREATMENT OF PARKINSON'S DISEASE | 2012 |
|
RU2661197C2 |
| CORTICOSTEROIDS FOR JOINT PAIN TREATMENT | 2011 |
|
RU2642279C2 |
| DELIVERED PHARMACEUTICAL COMPOSITIONS WITH CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS | 2005 |
|
RU2390355C2 |
| TRICYCLIC BENZODIAZEPINES, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND METHODS FOR HYPERTENSION TREATMENT | 1999 |
|
RU2250899C2 |
| PHARMACEUTICAL COMPOSITIONS WITH A SELECTED DURATION OF RELEASE | 2017 |
|
RU2756514C1 |
| HIGH STABILITY PHARMACEUTICAL COMPOSITIONS | 2007 |
|
RU2427383C2 |
| PRODRUG 1,3-DIAMINO-2-HYDROXYPROPANE DERIVATIVES | 2003 |
|
RU2357962C2 |
| COMBINATION, INCLUDING A) PYRIMIDYLAMINOBENZAMIDE AND B) KINASE Thr315lle INHIBITOR | 2007 |
|
RU2481840C2 |
